Revolution Medicines, Inc. RVMD
Set alert
194.32 USD +6.15 +3.27%
As of Nov 3, 10:00 AM ET
188.63 Day range 197.00
58.57 52-week range 221.15
- YTD
- +143.96%
- 1 year
- +227.52%
- Open
- 188.63
- Prev close
- 188.17
- Mkt cap
- 41.57B
- Vol
- 105.54K
- Avg vol
- 1.92M
- EPS
- -8.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 188.63
- High
- 197.00
- Forward P/E
- -32.65
- Beta
- 1.43
- Short ratio
- 5.55
- Inst. own
- 103.33%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 199.22
- 200-d avg
- 156.04
- 1y target
- 258.84
MAX chart
Events in this range
- Aug 6, 2025Earnings: -1.31; estimate -1.138; surprise -15.11%
- Nov 5, 2025Earnings: -1.61; estimate -1.42; surprise -13.38%
- Feb 25, 2026Earnings: -1.86; estimate -1.58; surprise -17.72%
- May 6, 2026Earnings: -2.29; estimate -1.84; surprise -24.46%
- Aug 5, 2026Earnings: -3.06; estimate -2.04; surprise -50%
- Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 14, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 15, 2026Rating: Needham · Buy → Buy
- Oct 16, 2026Rating: William Blair · — → Outperform
- Oct 19, 2026Rating: Truist Securities · Buy → Buy
- Oct 21, 2026Rating: TD Cowen · Buy → Buy
- Nov 4, 2026Earnings: —; estimate -2.35; surprise —%
Signals (111)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
Newest 20 of 111.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 258.84 +33.2% upside
Now 194.32
- Target (low)
- 179.00
- Target (mean)
- 258.84
- Target (high)
- 320.00
Ratings (0m) 25 24 buy · 1 hold · 0 sell
- Strong buy5
- Buy19
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 25
- 1 month ago 23
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.38 | -3.24 – -2.07 | -1.61 | -47.9% | 27.35M | 0.0% | 21 |
| Next quarter | -1.98 | -3.53 – -0.53 | -1.86 | -6.3% | 167.43M | 0.0% | 21 |
| Current year | -9.58 | -12.17 – -8.21 | -5.95 | -61.0% | 200.82M | 0.0% | 24 |
| Next year | -5.76 | -9.91 – -1.91 | -9.58 | +39.8% | 1.26B | +526.6% | 24 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Oct 19, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 15, 2026 | Needham | Reiterated | Buy | Buy |
| Oct 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 28, 2026 | Brookline Capital | Initiated | — | Buy |
| Sep 21, 2026 | B of A Securities | Maintained | Buy | Buy |
| Sep 10, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Sep 9, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 31, 2026 | Needham | Maintained | Buy | Buy |
| Aug 28, 2026 | UBS | Maintained | Buy | Buy |
| Aug 28, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 27, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 21, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Aug 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 6, 2026 | Needham | Maintained | Buy | Buy |
| Jul 23, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Needham | Maintained | Buy | Buy |
| Jul 9, 2026 | Guggenheim | Maintained | Buy | Buy |